DE60034110T2 - Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien - Google Patents

Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien Download PDF

Info

Publication number
DE60034110T2
DE60034110T2 DE60034110T DE60034110T DE60034110T2 DE 60034110 T2 DE60034110 T2 DE 60034110T2 DE 60034110 T DE60034110 T DE 60034110T DE 60034110 T DE60034110 T DE 60034110T DE 60034110 T2 DE60034110 T2 DE 60034110T2
Authority
DE
Germany
Prior art keywords
aminopyridine
nervous system
treatment
patients
demyelinating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60034110T
Other languages
German (de)
English (en)
Other versions
DE60034110D1 (de
Inventor
Jay M. Birmingham MEYTHALER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of DE60034110D1 publication Critical patent/DE60034110D1/de
Application granted granted Critical
Publication of DE60034110T2 publication Critical patent/DE60034110T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE60034110T 1999-02-09 2000-02-09 Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien Expired - Lifetime DE60034110T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11927399P 1999-02-09 1999-02-09
US119273P 1999-02-09
PCT/US2000/003396 WO2000047210A1 (en) 1999-02-09 2000-02-09 Use of 4-amino pyridine for treatment of peripheral neuropathies

Publications (2)

Publication Number Publication Date
DE60034110D1 DE60034110D1 (de) 2007-05-10
DE60034110T2 true DE60034110T2 (de) 2007-12-06

Family

ID=22383494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60034110T Expired - Lifetime DE60034110T2 (de) 1999-02-09 2000-02-09 Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien

Country Status (10)

Country Link
US (1) US6503931B1 (enExample)
EP (1) EP1152760B1 (enExample)
JP (1) JP2002536413A (enExample)
AT (1) ATE357914T1 (enExample)
AU (1) AU3360000A (enExample)
CA (1) CA2360326C (enExample)
DE (1) DE60034110T2 (enExample)
DK (1) DK1152760T3 (enExample)
ES (1) ES2284485T3 (enExample)
WO (1) WO2000047210A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820423B1 (fr) * 2001-02-05 2005-12-02 Assist Publ Hopitaux De Paris Tartrate et phosphate de 3,4-diaminopyridine, compositions pharmaceutiques et utilisations
US20050192321A1 (en) * 2003-09-15 2005-09-01 Meythaler Jay M. Treatment of neuropathy with rapid release aminopyridine
CA2840591A1 (en) 2011-06-30 2013-01-03 Biomarin Pharmaceuticals, Inc. Methods of administering 3,4-diaminopyridine
TWI592156B (zh) * 2011-10-04 2017-07-21 艾可達醫療公司 使用胺基吡啶以治療與中風有關之感覺動作損傷之方法
WO2014151752A1 (en) 2013-03-15 2014-09-25 University Of Rochester Composition and methods for the treatment of peripheral nerve injury
MA35698B1 (fr) * 2013-05-16 2014-12-01 Univ Mohammed V Souissi Nouvelle composition du 3,4-diaminopyridin pour le traitement de la fatigabilité musculaire associée à des troubles neurovégétatifs.
WO2024011220A1 (en) 2022-07-08 2024-01-11 University Of Rochester Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating tissue dysfunction caused by toxic insults

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221683A (en) * 1984-03-19 1993-06-22 The Rockefeller University Diaminopyridine compounds and methods of use
US4855290A (en) * 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
CA2085785C (en) * 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition

Also Published As

Publication number Publication date
JP2002536413A (ja) 2002-10-29
US6503931B1 (en) 2003-01-07
WO2000047210A1 (en) 2000-08-17
DK1152760T3 (da) 2007-07-30
ES2284485T3 (es) 2007-11-16
EP1152760A4 (en) 2005-03-23
EP1152760B1 (en) 2007-03-28
DE60034110D1 (de) 2007-05-10
ATE357914T1 (de) 2007-04-15
CA2360326A1 (en) 2000-08-17
AU3360000A (en) 2000-08-29
EP1152760A1 (en) 2001-11-14
CA2360326C (en) 2011-04-05

Similar Documents

Publication Publication Date Title
DE69507493T2 (de) Tirilazad parentale formulierung mit einem co-lösungsmittel
DE69629553T2 (de) Verfahren zur behandlung von interstitieller blasenentzündung mit hyaluronsäure
DE3856018T2 (de) Verwendung von einer Disaccharidpolysulfat-Aluminium Verbindung zur Herstellung eines Medikaments zur Behandlung von HÄMORRHOIDEN und zur Wundheilung
DE69908643T2 (de) Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen
DE69033863T2 (de) Verwendung von 5-methyl-1-phenyl-2-(1H)-pyridon zur Vorbeugung fibrotischer Schädigungen
DE60119534T2 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
JP3758164B2 (ja) 筋萎縮性側索硬化症（ａｌｓ）治療剤
DE69431433T2 (de) Zusammensetzungen und verfahren zur reparatur und vorbeugung fibrotischer verletzungen
Black et al. Tolerance and safety of ciprofloxacin in paediatric patients
DE60037816T2 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE68913907T2 (de) Methode zur Behandlung des interstitiellen Blasenentzündung.
DE69325574T2 (de) ANGIOTENSIN-II-ANTAGONISTEN GEGEN ERKRANKUNGEN; DIE MIT EINER EINGESCHRäNKTEN; NEURONALEN LEITUNGSGESCHWINDIGKEIT VERBUNDEN SIND, INSBESONDERE DIABETISCHE NEUROPATHIE
DE3390116C2 (de) Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE68908117T2 (de) N-Acetylglukosamin als zytoprotektives Mittel.
DE4232899C2 (de) Verwendung von NADH und NADPH zur Behandlung von Morbus Alzheimer
DE3390114T1 (de) Verbesserte analgetische und antiinflammatorische, Ibuprofen enthaltende Zubereitungen und Verfahren zu ihrer Herstellung
DE60034110T2 (de) Verwendung von 4-aminopyridin zur behandlung von peripheren neuropathien
DE602004009079T2 (de) Carbostyril-derivative zur beschleunigten speichelabsonderung
Saulino et al. The pharmacological management of spasticity
DE69303305T2 (de) Mittel zur Behandlung chronischer Ermüdungserscheinungen
DE60017733T2 (de) Verwendung von riluzol zur behandlung multipler sklerose
DE2206570B2 (de) Verwendung von ( + ) - Catechin
DE69630423T2 (de) Immunoglobuline die durch Mischung mit einem Komponenten von Histamin aktiviert wurden
DE60120917T2 (de) Kombinationspräparat zur krebstherapie
DE69904206T2 (de) Verwendung von cetirizin zur vorbeugung von asthma eintritt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition